|
Market Cap (5-Jun) $23,079,360 (1,609th) |
Close (25-Oct) $0.048 |
Volume (25-Oct) 0 |
Shortsold (25-Jun) 3,768 (0.00%) (647th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.019 |
SUD released this announcement to the ASX on 16 February 2021, 12:15. The announcement is not marked as price sensitive, and is 15 page(s) in length and 333.56kb in size.
You can view all announcements from SUD and see how they appear on a price chart on the announcements page.
At the date of this announcement, SUD was 0.001% short sold according to ASIC data. It was ranked the 647th most shorted stock on the ASX. It remains ranked 647th as of the latest reported data (25 June 2021).
| Other Recent Announcements from SUD | |
|---|---|
| SUDA becomes Arovella Therapeutics | 22 October 2021, 8:20 |
| Chile Ministry of Health Approval Granted for ZolpiMist | 21 October 2021, 10:00 |
| Results of General Meeting | 14 October 2021, 13:51 |
| Appendix 2A | 16 February 2021, 12:15 |
| Zelira Therapeutics Feasibility Study Update | 16 February 2021, 8:19 |
| Results of General Meeting | 29 January 2021, 15:32 |
| GM presentation | 29 January 2021, 9:12 |
You must be logged in to post a reply.
